Reqrea Exposed 1M Hotel Passports Without Password
Japanese startup Reqrea left 1 million hotel passports in a public S3 bucket anyone could read. Its investigation has no published timeline.
Japanese startup Reqrea left 1 million hotel passports in a public S3 bucket anyone could read. Its investigation has no published timeline.
Drift and Kelp DAO lost nearly $600M in April. Cybersecurity experts now say the speed of those attacks is consistent with AI assistance.
When FDA's CDER chief exits and other senior roles turn over at once, pharma has a genuine question: who's running the review process.
A federal judge stalled Anthropic's $1.5B copyright settlement Thursday, as authors earning $3,000 clash with lawyers seeking $320M in fees.
CFTC chairman Selig says the agency is chasing hundreds of insider trading tips on prediction markets, with AI surveillance tools now live.
Glass particles in 675 Sun Pharma cancer drug vials could trigger blood clots. The Indian plant making them has 10 years of FDA violations.
Senate committee cleared the CLARITY Act; banks are already lobbying to gut the stablecoin yield provisions before the floor vote.
The FTC's $53,088-per-violation deepfake rule starts May 19, and compliance attorneys already know which way platforms will lean on this.
Crypto's first federal rulebook passed committee 15-9, but needs 60 Senate floor votes and must clear a Trump family conflict-of-interest fight.
FDA's full clinical hold on ARD-101 sent Aardvark down 30%, and two analyst firms warn the cardiac signal may cap what safe doses can do.
SEC enforcement chief Woodcock commits to quality over quantity, signaling that borderline inquiries could quietly fall off the agency's docket.
Andrea Pfeifer ends her run at AC Immune, sending the company into its first-ever CEO search.
A federal judge wants answers on how Musk's SEC deal was reached, why it uses a trust, and whether White House meddling tainted the process.
Encoded's gene therapy hit 76% seizure reduction in Dravet syndrome kids. Trial details are sparse and no regulatory path has been announced.
Instacart's 23% grocery price gap experiment sparked a 26-state backlash: over 50 bills targeting AI surveillance pricing are now live.